Hippo (HIPO) Competitors $35.91 -0.74 (-2.02%) As of 12:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIPO vs. ALHC, BWIN, BHF, PLMR, NMIH, GSHD, CS, HG, SPNT, and FIHLShould you be buying Hippo stock or one of its competitors? The main competitors of Hippo include Alignment Healthcare (ALHC), Baldwin Insurance Group (BWIN), Brighthouse Financial (BHF), Palomar (PLMR), NMI (NMIH), Goosehead Insurance (GSHD), Credit Suisse Group (CS), Hamilton Insurance Group (HG), SiriusPoint (SPNT), and Fidelis Insurance (FIHL). These companies are all part of the "insurance" industry. Hippo vs. Its Competitors Alignment Healthcare Baldwin Insurance Group Brighthouse Financial Palomar NMI Goosehead Insurance Credit Suisse Group Hamilton Insurance Group SiriusPoint Fidelis Insurance Hippo (NYSE:HIPO) and Alignment Healthcare (NASDAQ:ALHC) are both insurance companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk. Do analysts rate HIPO or ALHC? Hippo presently has a consensus price target of $34.25, indicating a potential downside of 4.62%. Alignment Healthcare has a consensus price target of $18.83, indicating a potential upside of 7.16%. Given Alignment Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Alignment Healthcare is more favorable than Hippo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hippo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33Alignment Healthcare 1 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.75 Which has more volatility & risk, HIPO or ALHC? Hippo has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Do institutionals and insiders hold more shares of HIPO or ALHC? 43.0% of Hippo shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 10.8% of Hippo shares are held by insiders. Comparatively, 7.0% of Alignment Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings and valuation, HIPO or ALHC? Hippo has higher earnings, but lower revenue than Alignment Healthcare. Hippo is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHippo$372.10M2.42-$40.50M-$0.49-73.29Alignment Healthcare$2.70B1.29-$128.04M-$0.28-62.77 Is HIPO or ALHC more profitable? Alignment Healthcare has a net margin of -1.53% compared to Hippo's net margin of -2.52%. Hippo's return on equity of -12.13% beat Alignment Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Hippo-2.52% -12.13% -2.59% Alignment Healthcare -1.53%-43.68%-6.05% Does the media prefer HIPO or ALHC? In the previous week, Hippo had 5 more articles in the media than Alignment Healthcare. MarketBeat recorded 12 mentions for Hippo and 7 mentions for Alignment Healthcare. Alignment Healthcare's average media sentiment score of 0.72 beat Hippo's score of 0.09 indicating that Alignment Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hippo 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Alignment Healthcare 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAlignment Healthcare beats Hippo on 10 of the 17 factors compared between the two stocks. Get Hippo News Delivered to You Automatically Sign up to receive the latest news and ratings for HIPO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HIPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIPO vs. The Competition Export to ExcelMetricHippoINS IndustryFinance SectorNYSE ExchangeMarket Cap$897.20M$20.95B$12.57B$21.91BDividend YieldN/A2.60%5.54%3.58%P/E Ratio-73.1513.5230.1429.70Price / Sales2.422.3930.0263.33Price / CashN/A18.1222.5724.43Price / Book2.443.472.284.62Net Income-$40.50M$1.62B$1.02B$1.01B7 Day Performance0.02%-0.11%0.14%-0.08%1 Month Performance-2.76%-1.67%0.15%2.66%1 Year Performance114.00%17.02%539.55%14.83% Hippo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIPOHippo1.5107 of 5 stars$35.91-2.0%$34.25-4.6%+110.9%$897.20M$372.10M-73.15620Analyst DowngradeALHCAlignment Healthcare1.876 of 5 stars$17.45-0.5%$18.83+7.9%+50.9%$3.47B$2.70B-62.321,679Analyst ForecastBWINBaldwin Insurance Group3.6799 of 5 stars$27.90-2.5%$43.67+56.5%-42.8%$3.40B$1.44B-96.214,116News CoveragePositive NewsAnalyst UpgradeBHFBrighthouse Financial4.6107 of 5 stars$54.58-2.1%$59.67+9.3%+8.6%$3.19B$4.72B5.911,400Positive NewsAnalyst ForecastPLMRPalomar4.7325 of 5 stars$114.49-0.6%$165.83+44.8%+23.2%$3.09B$553.86M20.12150Analyst ForecastNMIHNMI3.8253 of 5 stars$38.69-1.5%$42.33+9.4%-12.6%$3.05B$650.97M8.21234Analyst ForecastGSHDGoosehead Insurance4.4317 of 5 stars$73.50-1.9%$108.91+48.2%-22.4%$2.81B$314.51M65.041,580Analyst ForecastHigh Trading VolumeCSCredit Suisse GroupN/A$0.89flatN/AN/A$2.77B$22.88B1.3750,480News CoverageHGHamilton Insurance Group2.4238 of 5 stars$24.59-0.2%$25.43+3.4%+37.3%$2.47B$2.33B6.79550News CoverageAnalyst ForecastSPNTSiriusPoint3.3944 of 5 stars$17.86-2.5%$25.00+40.0%+36.8%$2.14B$2.60B20.071,072Analyst ForecastFIHLFidelis Insurance3.6021 of 5 stars$17.55+0.1%$20.67+17.7%+8.6%$1.94B$2.42B-42.8177Analyst Forecast Related Companies and Tools Related Companies Alignment Healthcare Alternatives Baldwin Insurance Group Alternatives Brighthouse Financial Alternatives Palomar Alternatives NMI Alternatives Goosehead Insurance Alternatives Credit Suisse Group Alternatives Hamilton Insurance Group Alternatives SiriusPoint Alternatives Fidelis Insurance Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIPO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hippo Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hippo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
